SouthernWorldwide.com – Connecticut has confirmed its first case of clade I mpox, a more severe strain of the virus, following the patient’s recent travel to Western Europe.
The Centers for Disease Control and Prevention (CDC) identifies clade I mpox as a more virulent version of the virus that causes monkeypox. This confirmation in the U.S. comes as global health officials are also closely monitoring new hantavirus cases reported in Europe.
The Connecticut Department of Public Health (CDPH) announced on Wednesday that the state’s initial case of clade I mpox was detected in an individual who had recently visited Western Europe. Health authorities in that region are actively monitoring infectious disease activity.
Separately, the World Health Organization (WHO) has reported new hantavirus cases in Spain and France. This has brought renewed attention to hantavirus, a rare but potentially serious disease that can lead to significant respiratory complications in humans.
According to the WHO, hantavirus is primarily transmitted through contact with infected rodents. While it can cause severe respiratory illness, cases are considered infrequent.
Read more : Taiwan: China's Core Concern, America's Economic Anchor
Despite health officials stating that the current mpox case “does not pose a risk to the general public,” they are still urging individuals who might be at risk to get vaccinated with the JYNNEOS vaccine.
NEW MPOX STRAIN CONFIRMED IN US STATE FOR FIRST TIME
Symptoms of mpox, as outlined by the CDC, can include fever, swollen lymph nodes, and a distinctive rash.
“Mpox hasn’t gone away, and we want people to be protected, especially as many in our community prepare for travel, festivals, and gatherings this summer,” stated CDPH Commissioner Dr. Manisha Juthani in a press release. She emphasized the importance of vaccination.
“The vaccine is safe, effective, and widely available. Completing the two-dose series is the best way to protect yourself and your partners,” Dr. Juthani added.
HANTAVIRUS DEATHS ON CRUISE SHIP HIGHLIGHT DANGERS OF RODENT-BORNE DISEASE
The CDC and WHO explain that clade I and clade II are genetically distinct forms of the mpox virus, differing significantly in their severity and geographic origins.
Clade I, which has historically been identified in Central Africa, has been associated with more severe illness and higher mortality rates. Cases of clade I often present with more extensive rashes and complications.
In contrast, clade II has primarily circulated in West Africa and is generally linked to milder disease. This clade was responsible for the global outbreak that began in 2022, where most patients experienced less severe symptoms and had lower rates of hospitalization and death, according to the WHO.
Both the CDC and WHO emphasize that differentiating between these two clades is crucial for risk assessment, particularly as international travel continues to increase.
